These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 33510328)
21. The microRNA-15 family inhibits the TGFβ-pathway in the heart. Tijsen AJ; van der Made I; van den Hoogenhof MM; Wijnen WJ; van Deel ED; de Groot NE; Alekseev S; Fluiter K; Schroen B; Goumans MJ; van der Velden J; Duncker DJ; Pinto YM; Creemers EE Cardiovasc Res; 2014 Oct; 104(1):61-71. PubMed ID: 25103110 [TBL] [Abstract][Full Text] [Related]
22. MALAT1 Modulates TGF-β1-Induced Endothelial-to-Mesenchymal Transition through Downregulation of miR-145. Xiang Y; Zhang Y; Tang Y; Li Q Cell Physiol Biochem; 2017; 42(1):357-372. PubMed ID: 28535533 [TBL] [Abstract][Full Text] [Related]
24. Experimental evidences for hsa-miR-497-5p as a negative regulator of SMAD3 gene expression. Jafarzadeh M; Soltani BM; Dokanehiifard S; Kay M; Aghdami N; Hosseinkhani S Gene; 2016 Jul; 586(2):216-21. PubMed ID: 27063509 [TBL] [Abstract][Full Text] [Related]
25. Coordinate activities of BRD4 and CDK9 in the transcriptional elongation complex are required for TGFβ-induced Nox4 expression and myofibroblast transdifferentiation. Ijaz T; Jamaluddin M; Zhao Y; Zhang Y; Jay J; Finnerty CC; Herndon DN; Tilton RG; Brasier AR Cell Death Dis; 2017 Feb; 8(2):e2606. PubMed ID: 28182006 [TBL] [Abstract][Full Text] [Related]
26. Exosomes Derived from Human Adipose Mesenchymal Stem Cells Inhibits Fibrosis and Treats Oral Submucous Fibrosis via the miR-181a-5p/Smad2 Axis. Shao Z; Xu J; Xu X; Wang X; Zhou Y; Li Y; Li K Tissue Eng Regen Med; 2024 Jan; 21(1):123-135. PubMed ID: 37755664 [TBL] [Abstract][Full Text] [Related]
27. Specific Inhibitor of Smad3 (SIS3) Attenuates Fibrosis, Apoptosis, and Inflammation in Unilateral Ureteral Obstruction Kidneys by Inhibition of Transforming Growth Factor β (TGF-β)/Smad3 Signaling. Ji X; Wang H; Wu Z; Zhong X; Zhu M; Zhang Y; Tan R; Liu Y; Li J; Wang L Med Sci Monit; 2018 Mar; 24():1633-1641. PubMed ID: 29555895 [TBL] [Abstract][Full Text] [Related]
28. Overexpression of microRNA-21 mediates Ang II-induced renal fibrosis by activating the TGF-β1/Smad3 pathway via suppressing PPARα. Lyu H; Li X; Wu Q; Hao L J Pharmacol Sci; 2019 Sep; 141(1):70-78. PubMed ID: 31611175 [TBL] [Abstract][Full Text] [Related]
29. Sirtuin 6 deficiency transcriptionally up-regulates TGF-β signaling and induces fibrosis in mice. Maity S; Muhamed J; Sarikhani M; Kumar S; Ahamed F; Spurthi KM; Ravi V; Jain A; Khan D; Arathi BP; Desingu PA; Sundaresan NR J Biol Chem; 2020 Jan; 295(2):415-434. PubMed ID: 31744885 [TBL] [Abstract][Full Text] [Related]
30. Transforming growth factor (TGF)-β1-induced miR-133a inhibits myofibroblast differentiation and pulmonary fibrosis. Wei P; Xie Y; Abel PW; Huang Y; Ma Q; Li L; Hao J; Wolff DW; Wei T; Tu Y Cell Death Dis; 2019 Sep; 10(9):670. PubMed ID: 31511493 [TBL] [Abstract][Full Text] [Related]
33. miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-β/Smad3 signaling. Zhang Y; Huang XR; Wei LH; Chung AC; Yu CM; Lan HY Mol Ther; 2014 May; 22(5):974-85. PubMed ID: 24569834 [TBL] [Abstract][Full Text] [Related]
34. miR-96-5p regulates myocardial infarction-induced cardiac fibrosis via Smad7/Smad3 pathway. Gu H; Duan Y; Li S; Wang Q; Zhen W; Zhang W; Zhang Y; Jiang M; Wang C Acta Biochim Biophys Sin (Shanghai); 2022 Dec; 54(12):1874-1888. PubMed ID: 36789690 [TBL] [Abstract][Full Text] [Related]
35. 3D hESC exosomes enriched with miR-6766-3p ameliorates liver fibrosis by attenuating activated stellate cells through targeting the TGFβRII-SMADS pathway. Wang N; Li X; Zhong Z; Qiu Y; Liu S; Wu H; Tang X; Chen C; Fu Y; Chen Q; Guo T; Li J; Zhang S; Zern MA; Ma K; Wang B; Ou Y; Gu W; Cao J; Chen H; Duan Y J Nanobiotechnology; 2021 Dec; 19(1):437. PubMed ID: 34930304 [TBL] [Abstract][Full Text] [Related]
36. The Role of c-SKI in Regulation of TGFβ-Induced Human Cardiac Fibroblast Proliferation and ECM Protein Expression. Wang J; Guo L; Shen D; Xu X; Wang J; Han S; He W J Cell Biochem; 2017 Jul; 118(7):1911-1920. PubMed ID: 28214335 [TBL] [Abstract][Full Text] [Related]
37. PU.1 inhibition attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin-II by reducing TGF-β1/Smads pathway activation. Hu J; Zhang JJ; Li L; Wang SL; Yang HT; Fan XW; Zhang LM; Hu GL; Fu HX; Song WF; Yan LJ; Liu JJ; Wu JT; Kong B J Cell Mol Med; 2021 Jul; 25(14):6746-6759. PubMed ID: 34132026 [TBL] [Abstract][Full Text] [Related]
38. Astragaloside IV inhibits cardiac fibrosis via miR-135a-TRPM7-TGF-β/Smads pathway. Wei Y; Wu Y; Feng K; Zhao Y; Tao R; Xu H; Tang Y J Ethnopharmacol; 2020 Mar; 249():112404. PubMed ID: 31739105 [TBL] [Abstract][Full Text] [Related]